4.6 Letter

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

Journal

NATURE REVIEWS CLINICAL ONCOLOGY
Volume 15, Issue 4, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2018.19

Keywords

-

Categories

Funding

  1. Novartis
  2. Juno Therapeutics

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available